7. Rathore SS, Metha SS, Boyko WL Jr, Schulman KA. Prescription medication use in older Americans: a national report card on prescribing. Fam Med 1998;30:733-739.
8. Giron MS, Wang HX, Bernstein C, Thorslund M, Winblad B, Fastbom J. The appropriateness of drug use in an older non-demented and demented population. J Am Geriatr Soc 2001;49:277-283.
9. Fugh-Berman A. Herb-drug interactions. Lancet 2000;355:134-138.
10. Beyth RJ, Antani MR, Covinsky KE, Miller DG, Chren MM, Landefeld CS, et al. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? A study of physician's opinions and their relationship to clinical characteristics and the physician's prescribing practices J Gen Intern Med 1996;11:721-728.
11. Fouts M, Hanlon J, Pieper C, Perfetto E, Feinberg J. Identification of elderly nursing facility residents at high risk for drug-related problems. Consult Pharm 1997;12:1103-1111.
12. Black DM, Brand RJ, Greenlick M, Hughes G, Smith J. Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. J Gerontol 1987;43:552-557.
13. Botelho RJ, Dudrak R. Home assessment of adherence to long-term medication in the elderly. J Fam Pract 1992;35:61-65.
14. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
15. Cooper JK, Love DW, Raffoul PR. Intentional prescription nonadherence by the elderly. J Am Geriatr Soc 1982;30:329-333.
16. Kane RL, Ouslander JG, Abrass IB. Essentials of clinical geriatrics 1999;4th ed. New York: McGraw-Hill. 383.
17. Hutchinson TA, Flegel KM, Kramer MS, Leduc DG, Kong HH. Frequency, severity and risk factors for adverse drug reactions in adult outpatients: a prospective study. J Chron Dis 1986;39:533-542.
18. Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery RP. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988;36:1092-1098.
19. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:1531-1536.
20. Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000;34:338-346.
21. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991;114:956-966.
22. Hurwitz N. Predisposing factors in adverse reactions to drugs. BMJ 1969;1:536-539.
23. Johnson JA, Bootman JL. Drug-related morbidity and mortality : a cost-illness model. Arch Intern Med 1995;155:1949-1956.
24. Klein U, Klein M, Sturm H, et al. The frequency of adverse drug reactions as dependent upon age, sex, and duration of hospitalization. Int J Clin Pharmacol Biopharm 1976;13:187-195.
25. Michocki RJ. In: Daly MP, Weiss BD, Adelman AM, editor. Polypharmacy and principles of drug therapy. 20 common problems in geriatrics 2001;New York: McGraw-Hill. 69-81.
26. Rochon PA, Gurwitz JH. Prescribing for seniors: neither too much nor too little. JAMA 1999;282:113-115.